Search Results 1011-1020 of 17122 for monoclonal antibody

1. A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) - Mayo Clinic

   ... monoclonal antibodies. Has evidence of ongoing uncontrolled systemic bacterial, fungal, or viral infection. Note: Subjects with localized fungal infections ...

2. Varicella-zoster immune globulin (intramuscular route) - Side effects & uses - Mayo Clinic

   This passive protection lasts long enough to protect your body until your body can produce its own antibodies against VZV. Varicella (commonly known as ...

3. A Study of the Safety and Effectiveness of GS-5745 in Participants with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Treatment with any monoclonal antibody within 4 weeks of screening; History or evidence of colonic mucosal dysplasia; HIV, hepatitis B, hepatitis C, or ...

4. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

   History of severe allergic or anaphylactic reactions to human, humanized or murine monoclonal antibodies. ... antibody-forming cells and of T cells into effector ...

5. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

   Prior immunotherapy (monoclonal antibodies) ≤ 3 weeks prior to registration; ... Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies).

6. A Study of the Effectiveness and Safety of Pembrolizumab (MK-3475) for Women with Advanced Recurrent Ovarian Cancer - Mayo Clinic

   Has had prior anti-cancer monoclonal antibody (mAb), chemotherapy, targeted small molecule therapy, or radiation therapy within 4 weeks prior to the planned ...

7. A Study to Investigate Intravenous Tocilizumab in Patients with Moderate-to-Severe COVID-19 Pneumonia (enrolling by invitation only) - Mayo Clinic

   Known severe allergic reactions to TCZ or other monoclonal antibodies;; Active TB infection;; Suspected active bacterial, fungal, viral, or other infection ...

8. Clinical trials - Oncology (Medical)

   A Study of Hematopoiesis in Patients with Monoclonal ... Monoclonal B Cell Lymphocytosis (MBL) and B ... antibodies) treatment, CPI-naïve hepatocellular ...

9. Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer - Mayo Clinic

   Prior therapy with monoclonal antibodies or small molecule inhibitors against Vascular endothelial growth factor (VEGF) or VEGF receptors, including Avastin® or ...

10. A Study to Assess the Effectiveness and Safety of Ublituximab in combination with Umbralisib and Venetoclax (U2-V) Compared to Ublituximab and Umbralisib (U2) in Subjects with Chronic Lymphocytic Leukemia (CLL) - Mayo Clinic

    ... antibody (HCV ... History of anaphylaxis (excluding infusion related reactions) in association with previous anti-CD20 monoclonal antibody administration.